Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Some one in six people over the age of 45 have a condition called low vision, where they have trouble reading, driving, or telling colors apart. And that number rises to one in four in those over the age of …
Low vision is much more common than you might think, Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
Low vision, which affects one in four adults over 75, is often associated with damage to the macula, the part of the eye where our vision usually works best. Judith Goldstein, a low vision expert at Johns Hopkins, says there …
Can anything be done about low vision? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 5:22 — 7.4MB)
Subscribe: RSS
HPV causes cancer, and we have an effective vaccine against it. Now the World Health Organization is advocating for a single dose of the vaccine in places where completing the two dose regimen is challenging. Johns Hopkins Kimmel Cancer Center …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Breakthrough infections, which occur in those who have been vaccinated against Covid-19, are more troubling for people with cancer than those without, a new study confirms. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, reviews the data. …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
People with cancer who have been vaccinated against Covid-19 remain at increased risk for infection compared with people who don’t have cancer, a very large new study reveals. Johns Hopkins Kimmel Cancer Center director William Nelson describes the findings. Nelson: …
Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
An immunotherapy agent called nivolumab given before surgery in people with lung cancer dramatically lengthened the interval before cancer returned, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, is thrilled. Nelson: Will we …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Nivolumab is the name of an immunotherapy used to treat cancer, and a recent study of people with lung cancer using it before surgery shows it really helps. Johns Hopkins Kimmel Cancer Center director William Nelson explains. Nelson: Three hundred …
